Sandro Mazzaferro

Summary

Affiliation: University of Rome La Sapienza
Country: Italy

Publications

  1. ncbi request reprint Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis
    Sandro Mazzaferro
    Division of Nephrology, Department of Clinical Science, University of Rome La Sapienza, Rome, Italy
    Am J Nephrol 27:75-83. 2007
  2. doi request reprint Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23
    Sandro Mazzaferro
    Department of Cardiovascular, Respiratory, Nephrological and Geriatric Sciences, Sapienza University of Rome, Rome, Italy
    J Nephrol 25:1108-18. 2012
  3. ncbi request reprint Treatment of cardiovascular calcification in uremia
    Sandro Mazzaferro
    Department of Cardiovascular, Respiratory, Nephrologic and Geriatric Sciences, University of Rome Sapienza, Policlinico Umberto I, Rome, Italy
    Curr Vasc Pharmacol 9:741-9. 2011
  4. doi request reprint Does any therapy exist for vascular calcifications in uremia?
    Sandro Mazzaferro
    Department of Cardiovascular, Respiratory, Nephrologic and Geriatric Sciences, Sapienza University of Rome, Rome, Italy
    J Nephrol 24:S16-24. 2011
  5. ncbi request reprint Management of secondary hyperparathyroidism in Italy: results of the Italian FARO survey
    Sandro Mazzaferro
    Clinical Science, Sapienza University, Rome, Italy
    J Nephrol 24:225-35. 2011
  6. doi request reprint The bone and the kidney
    Sandro Mazzaferro
    Department of Clinical Science, Sapienza University of Rome, Italy
    Arch Biochem Biophys 503:95-102. 2010
  7. ncbi request reprint [Pathophysiology of secondary hyperparathyroidism: the role of FGF23 and Klotho]
    S Mazzaferro
    Dipartimento di Scienze Cliniche, Nefrologia, Policlinico Umberto I, Roma Italy
    G Ital Nefrol 26:S11-7. 2009
  8. pmc Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation
    Sandro Mazzaferro
    Department of Clinical Science, University of Rome La Sapienza, Rome, Italy
    Clin J Am Soc Nephrol 4:685-90. 2009
  9. doi request reprint Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients
    Sandro Mazzaferro
    Department of Clinical Science, Sapienza University of Rome, Italy
    Nephrol Dial Transplant 23:2319-23. 2008
  10. ncbi request reprint [Comparison among ecography, scintigraphy and surgery in the localization of parathyroid glands in uremic patients undergoing parathyroidectomy]
    S Mazzaferro
    Cattedra di Nefrologia, Universita di Roma La Sapienza, Roma, Italia
    Clin Ter 157:413-7. 2006

Detail Information

Publications20

  1. ncbi request reprint Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis
    Sandro Mazzaferro
    Division of Nephrology, Department of Clinical Science, University of Rome La Sapienza, Rome, Italy
    Am J Nephrol 27:75-83. 2007
    ....
  2. doi request reprint Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23
    Sandro Mazzaferro
    Department of Cardiovascular, Respiratory, Nephrological and Geriatric Sciences, Sapienza University of Rome, Rome, Italy
    J Nephrol 25:1108-18. 2012
    ....
  3. ncbi request reprint Treatment of cardiovascular calcification in uremia
    Sandro Mazzaferro
    Department of Cardiovascular, Respiratory, Nephrologic and Geriatric Sciences, University of Rome Sapienza, Policlinico Umberto I, Rome, Italy
    Curr Vasc Pharmacol 9:741-9. 2011
    ..Drugs capable of reversing the process of trans-differentiation from osteoblast-like to vascular smooth muscle cells could be developed in the future...
  4. doi request reprint Does any therapy exist for vascular calcifications in uremia?
    Sandro Mazzaferro
    Department of Cardiovascular, Respiratory, Nephrologic and Geriatric Sciences, Sapienza University of Rome, Rome, Italy
    J Nephrol 24:S16-24. 2011
    ..However, to this purpose, selection of the most appropriate strategy in the individual patient seems essential...
  5. ncbi request reprint Management of secondary hyperparathyroidism in Italy: results of the Italian FARO survey
    Sandro Mazzaferro
    Clinical Science, Sapienza University, Rome, Italy
    J Nephrol 24:225-35. 2011
    ..g., paricalcitol, calcimimetics). To determine the impact these new treatments have on achieving K/DOQI targets, an observational, prospective survey was undertaken...
  6. doi request reprint The bone and the kidney
    Sandro Mazzaferro
    Department of Clinical Science, Sapienza University of Rome, Italy
    Arch Biochem Biophys 503:95-102. 2010
    ..Kidney and bone communicate reciprocally to regulate the sophisticated machinery responsible for divalent ions homeostasis and for osseous or extraosseous mineralisation processes...
  7. ncbi request reprint [Pathophysiology of secondary hyperparathyroidism: the role of FGF23 and Klotho]
    S Mazzaferro
    Dipartimento di Scienze Cliniche, Nefrologia, Policlinico Umberto I, Roma Italy
    G Ital Nefrol 26:S11-7. 2009
    ..These new actors allow us to identify a bone-kidney axis, whose real physiological importance is still under evaluation...
  8. pmc Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation
    Sandro Mazzaferro
    Department of Clinical Science, University of Rome La Sapienza, Rome, Italy
    Clin J Am Soc Nephrol 4:685-90. 2009
    ..Transplantation should favorably affect coronary calcification (CAC) progression in dialysis; however, changes in CAC score in the individual patient are not reliably evaluated...
  9. doi request reprint Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients
    Sandro Mazzaferro
    Department of Clinical Science, Sapienza University of Rome, Italy
    Nephrol Dial Transplant 23:2319-23. 2008
    ....
  10. ncbi request reprint [Comparison among ecography, scintigraphy and surgery in the localization of parathyroid glands in uremic patients undergoing parathyroidectomy]
    S Mazzaferro
    Cattedra di Nefrologia, Universita di Roma La Sapienza, Roma, Italia
    Clin Ter 157:413-7. 2006
    ....
  11. ncbi request reprint Utilization of guidelines for the management of hypertension in cardiovascular risk scoring of renal patients
    S Mazzaferro
    Department of Clinical Science, University La Sapienza of Rome, Italy
    Clin Ter 157:327-32. 2006
    ....
  12. ncbi request reprint Ionised and total serum magnesium in renal transplant patients
    Sandro Mazzaferro
    Department of Clinical Science, University La Sapienza, Rome, Italy
    J Nephrol 15:275-80. 2002
    ....
  13. ncbi request reprint Morphometric X-ray absorptiometry in the assessment of vertebral fractures in renal transplant patients
    Sandro Mazzaferro
    Department of Clinical Science, University La Sapienza of Rome, Italy
    Nephrol Dial Transplant 21:466-71. 2006
    ..Moreover, the association of bone fractures with low BMD values was examined...
  14. ncbi request reprint How can we assess bone resorption in uremia?
    Sandro Mazzaferro
    Department of Clinical Science, Nephrology, University La Sapienza, Rome, Italy
    Nephron Clin Pract 98:c103-4. 2004
  15. ncbi request reprint [Update on the pathogenesis and possible therapeutic approach to vascular calcifications in patients with chronic renal failure]
    Marzia Pasquali
    Dipartimento di Scienze Cardiovascolari, respiratorie, Nefrologiche e Geriatriche dell Universita Sapienza di Roma, Roma, Italy
    G Ital Nefrol 28:514-24. 2011
    ....
  16. ncbi request reprint Vitamin D receptor activators
    Sandro Mazzaferro
    Department of Clinical Science, Sapienza University of Rome and Chair of Nephrology, Sapienza University of Rome, Rome Italy
    Int J Artif Organs 32:101-7. 2009
    ..In this review we provide a brief description of the drugs that have been developed more specifically for the treatment of secondary hyperparathyroidism (SH) associated with uremia...
  17. ncbi request reprint Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone
    S Minisola
    Department of Clinical Sciences, University of Rome La Sapienza, Italy
    Osteoporos Int 13:171-5. 2002
    ..Moreover, compared with normal subjects, serum betaCTx seems to be characterized by a superior sensitivity relative to TRAP measurement, at least in the disorders studied...
  18. ncbi request reprint [Is there any role predictable for bone morphogenetic protein-7 in nephrology?]
    S Mazzaferro
    Dipartimento di Scienze Cliniche Nefrologia, Policlinico Umberto I, Roma, Italy
    G Ital Nefrol 23:129-37. 2006
    ..Clinical data in nephropathic patients are therefore warranted to rule out the true value of this, very interesting, new molecule...
  19. ncbi request reprint Vascular calcification and uremia: what do we know?
    Mario Cozzolino
    Renal Division, S Paolo Hospital, University of Milan, Milan, Italy
    Am J Nephrol 28:339-46. 2008
    ..We conclude that at present it is too early to introduce these novel markers into clinical practice...
  20. ncbi request reprint [The role of intraoperative parathyroid hormone assay in the surgical management of hyperparathyroidism]
    Anna Maria Romani
    Universita degli Studi di Roma La Sapienza, Policlinico Umberto I, Dipartimento di Scienze Chirurgiche, U O C Chirurgia Generale ed Endocrina
    Ann Ital Chir 78:91-6. 2007
    ..A 50% reduction of the intraoperative PTH level, mesured within 15 minutes with an immunochemestry system of III generation (ICMA), shows the completeness of the hypersecretive tissues surgical removal...